The latest research study Peripheral Vascular Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” by IMARC Group, finds that The global peripheral vascular devices market size reached US$ 10.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 16.0 Billion by 2028, exhibiting a growth rate (CAGR) of 6.8% during 2023-2028.

Peripheral vascular devices are used to treat arterial narrowing and blockages found in peripheral vasculature caused by plaque build-up that restricts the blood vessels and reduces blood flow to the body parts. They include angioplasty catheters, peripheral guidewires, vena cava filters, stent-grafts, and embolic protection devices (EPD). Since they are safe, reduce the risk of infection and irritation, enhance blood flow and supply oxygenated blood through arteries, peripheral vascular devices are gaining immense traction across the globe.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request a free sample brochure: https://www.imarcgroup.com/peripheral-vascular-devices-market/requestsample

Peripheral Vascular Devices Market Trends and Drivers: 

The global peripheral vascular devices market is primarily driven by the rising prevalence of chronic venous insufficiency (CVI) and venous diseases. Moreover, the changing lifestyle habits, such as smoking, high alcohol consumption, physical inactivity, and unhealthy dietary habits, are also accelerating the product adoption rate. In line with this, the expanding geriatric population and the rising incidences of numerous ailments, such as peripheral artery disease (PAD) and blockages, are positively influencing the market growth. Additionally, there has been a surging adoption of atherectomy devices due to the rising prevalence of atherosclerosis, obesity, and lifestyle-related disorders. Along with this, the shifting consumer preferences for minimally invasive procedures (MIS) due to fewer complications, less postoperative pain, shortened hospital stays and faster recovery times represents another major growth-inducing factor. Other factors, including ongoing research and development (R&D) activities, rapid expansion in the healthcare industry and inflating consumer disposable incomes, are also anticipated to propel the market growth.

Ask An Analyst: https://www.imarcgroup.com/peripheral-vascular-devices-market

Peripheral Vascular Devices Market Report Segmentation 2023-2028:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Abbott Laboratories, B. Braun SE (B. Braun Holding GmbH & Co. KG), Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Group Incorporated, Cordis Corporation, iVascular S.L.U., Koninklijke Philips N.V., Medtronic plc and Terumo Medical Corporation.

The report has been segmented the market into following categories:

Breakup by Device Type:

  • Peripheral Vascular Stents
  • Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
  • Peripheral Transluminal Angioplasty (PTA) Guidewires
  • Atherectomy Devices
  • Embolic Protection Devices
  • Inferior Vena Cava Filters
  • Others

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Care Centers
  • Specialty Clinics
  • Others

Breakup By Regions:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Key highlights of the report:

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

 About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800